Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 5, 2026
Back to directoryDeep Bio DeepDx Prostate medical AI product profile
CE-marked and Korea MFDS-approved prostate pathology AI that analyzes digitized H&E slides for cancer detection and Gleason-pattern support under pathologist review.
Digital pathology
Best fit
Labs evaluating prostate core needle biopsy AI where pathologists can validate slide quality, review overlays, edit findings, and govern reporting responsibility.
- Primary use case
- AI diagnostic-support workflow for prostate H&E whole-slide images, cancer detection, Gleason-pattern localization, quantification, and pathologist review
- Audience
- Anatomic pathology labs, prostate cancer programs, digital pathology teams, and pathology AI governance committees
- Risk level
- High
- Pricing signal
- Enterprise pathology software pricing is not public; verify module, viewer, integration, deployment, service, and regional terms.
- Official sources
- 4 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Deep Bio DeepDx Prostate as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm the exact DeepDx Prostate module, specimen type, region, CE or MFDS status, and U.S. RUO limitation; do not treat CE or Korea MFDS approval as FDA clearance. |
|---|---|
| Privacy | Review cloud or on-premise architecture, WSI and metadata handling, LIS/viewer integration, access controls, support access, retention, regional hosting, and customer data-processing terms. |
| Evidence | Evaluate validation evidence and local performance for prostate biopsy slides, scanner/stain variability, Gleason-pattern accuracy, false-negative risk, edit burden, and final-report impact. |
| Workflow | Best governed as pathologist-supervised diagnostic support with mandatory overlay review, editable annotations, exception tracking, second-read escalation, and manual signout fallback. |
Where Deep Bio DeepDx Prostate fits
Deep Bio describes DeepDx Prostate as clinically validated, CE-marked, Korea MFDS-approved AI diagnostic-support software for prostate cancer H&E slides, with cloud and on-premise deployment options, Gleason-pattern overlays, quantification features, and published validation references; its product materials also state that DeepDx solutions are not FDA-cleared and are research-use-only in the United States.
Not for: U.S. diagnostic use without separate clearance, unsupported tissue or scanner workflows, autonomous signout, or applying prostate-module claims to breast or frozen-section modules.
What to verify before using Deep Bio DeepDx Prostate
- Exact DeepDx Prostate module, specimen type, scanner, viewer, geography, CE or MFDS status, and whether the U.S. workflow is research-use-only.
- How overlays, Gleason-pattern metrics, tumor quantification, annotation edits, and final report language are reviewed and approved by pathologists.
- Cloud versus on-premise deployment, WSI transfer, LIS or image-management integration, access controls, support access, retention, and regional hosting requirements.
- Local validation for core needle biopsy case mix, artifacts, benign mimics, high-grade patterns, turnaround time, sensitivity, specificity, and pathologist disagreement handling.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- deepbio.co.kr / products / prostate-cnb
- deepbio.co.kr / products
- indicalab.com / news / press-release-deep-bio-successfully-integrates-deepdx-prostate-algorithm-into-halo-ap-platform-from-indica-labs
- www.fda.gov / medical-devices / 510k-clearances
Related medical AI products
Digital pathology
PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Hologic Genius Digital Diagnostics
FDA-cleared digital cytology system combining volumetric imaging, Genius Cervical AI, image management, and cytologist or pathologist review.
Digital pathology
Ibex Medical Analytics
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.